Dynamk Capital collects capital for early-stage life sciences fund
Dynamk Capital has raised an undisclosed amount of capital in the first close of its early-stage venture fund focused on life sciences companies that provide tools, technologies and services. The fund is expected to close next year and will invest in eight to 10 companies.
26 September 2017•2 mins read
